...home visits from an average of 10,000 to 120,000 per week. By the end of FY 2020, their goal is to deliver all primary care and mental health provider services, both in-person and via a mobile or web-based device. The VA release from November 2019 does not break out the different types of VA telehealth and usage. Philips and BioIntelliSense have also inked a partnership deal to integrate BioIntelliSense’s BioSticker sensors into their post-acute remote patient monitoring (RPM) systems. The BioSticker is a wearable FDA-cleared 510(k) Class II sensor that transmits passive monitoring of key vital signs, physiological biometrics, and... Continue Reading
Search Results for sensor patches
News Roundup (updated): Proteus files Ch. 11, VA’s EHR tests now fall–maybe, making US telehealth expansion permanent, Rennova’s rural telehealth bet, Oysta’s Lite, Fitbit’s Ready to Work jumps on the screening bandwagon
Proteus Health, the company which pioneered what was initially derided as a ‘tattletale pill’, filed Chapter 11 bankruptcy today (16 June). As early as December, their layoffs of nearly 300 and closure of several sites was a strong clue that, as we put it, Proteus would be no-teous without a big win. Exactly the opposite happened with the unexpected early end of their Otsuka partnership with Abilify [TTA 17 Jan]. Proteus had raised about $500 million in venture capital from Novartis plus technology investors and family offices. Their combination of a pill with an ingestible sensor, a patch that detects... Continue Reading
News roundup: LabCorp CRO boosts Medable, Propeller Health gains 510(k), EU’s 34 medtech startups, Amazon’s healthcare moves, Google’s Arizona privacy lawsuit
...likely a bargain) purchase. Propeller Health, which specializes in digital respiratory health with sensors connected to inhalers and apps, gained 510(k) FDA clearance for a sensor/app for use with AstraZeneca’s Symbicort inhaler. This medication is used for asthma and COPD. It does not seem that long ago (2014) that the startup was at trade shows like NYeC and mHealth Summit with an exceedingly modest display of popups and brochures. Their 2019 acquisition by ResMed for the stunningly premium price of $225 million made news in late 2018. Mobihealthnews In Europe, COVID-19 has boosted at least 34 medtech startups, including 11... Continue Reading
NHSX announces TechForce19 challenge awards (updated), COVID-19 contact tracing app in test for mid-May launch (UK)
...April, and the selection announced on 24 April. Each finalist is being awarded up to £25,000 for further development of their technology systems. The 18 finalists include a number of familiar names to our Readers (who also may be part of these organizations): Feebris, Neurolove, Peppy, Vinehealth, Beam, TeamKinetic, Alcuris MemoHub, Ampersand Health, Aparido, Birdie, Buddi Connect, Just Checking, Peopletoo/Novoville, RIX Research & Media (University of East London), SimplyDo, SureCert, VideoVisit, and Virti. Their systems include checking for the most vulnerable, volunteering apps, mental health support, remote monitoring, home care management, and in-home sensor-based behavioral tracking. Details on each are... Continue Reading
CEO to CEO: TSA’s Alyson Scurfield interview with Tunstall CEO Gordon Sutherland (updated)
...an unexited portfolio company (or ‘unrealised’ in a more delicate term). Another reveal in this conversation is a strategic statement that segments care and presumably the company’s direction into four parts, somewhat like Roman Gaul (which was three or five, depending on the history you’re reading): Reactive care: for instance an alarm bell or PERS press Proactive care: reactive plus social care and well checks Predictive care: sensor-based tracking in the home. Presumably this would be rules-based (i.e. time) on ADLs. Tunstall has added to this Cognitive Care or “Intelli-Care” which would combine presumably #2 and #3 along with other... Continue Reading
Beyond telehealth: sensor-based vital signs monitoring for early coronavirus symptoms being tested in Israel
...Japan for airport arrival testing and, with other tests, during the Ebola event in the US. The dedicated sensors can operate through walls and objects, are not line-of-sight, and are not influenced by lighting. They can map environments and track movements in real-time. The tests are being run with MAFAT (Israel’s Defense Research & Development Directorate) and Israel’s Naval Medical Institute to run real-time monitoring with their personnel to detect early signs of the COVID-19 virus. The Israel National Emergency Team completed an earlier test in which two Vayyar sensor systems were adapted to remotely analyze patient data. Vayyar release.... Continue Reading
Virus-(almost) free news: Cera’s $70m raise, Rx.Health’s RxStitch, remote teledentistry to rescue, Alcuris responds, Caravan buys Wellpepper, and Teladoc’s heavy reading
Keeping calm and carrying on (but taking precautions, staying inside, and keyboarding with hands that resemble gator hide), yes, there IS some news that isn’t entirely about COVID-19: This Editor had put aside the $70 million funding by the UK’s Cera at end of February. What is interesting is that Cera Care is a hybrid–specializing in both supplying home-based care, including dementia care, and providing tech-enabled services for older adults. The funding announcement was timed with the intro of SmartCare, a sensor-based analytics platform that uses machine learning and data analytics on recorded behaviors to personalize care and detect health... Continue Reading
CES roundup: what happened to the excitement around ‘innovation’, robots, VR, and voice assistants?
...your fitness. That is, if you don’t step on it, mistake it for a tennis ball, or your dog doesn’t mistake it for a chew toy. The Charmin Rollbot will deliver a pre-loaded roll when you most need it, navigating through your home, although no capability of climbing stairs in its current concept. The Misty II robot is yet again one of those tabletop robots which are developer toys. This one propels itself and has a camera, a microphone and 3D sensors, and could be repurposed for fall detection, companionship, or to bring you a hot towel. The Lovot is... Continue Reading
The CES circus opens its largest tent yet in health tech, AI, 5G, and more
...ECG and monitor for sleep apnea. The ECG has three leads on the watch on the side of the watch’s bezel and an SpO2 sensor to monitor apneic episodes and oxygen saturation. FDA and CE approval are pending, and when released later this year will cost $249 to $299 depending on size. ZDNet ZDNet and TechRepublic have a running special feature on CES’ big trends for business. The annoyance factor you’ll have to endure is the running CBS commercials for various programs. Mobihealthnews rounds up interesting devices and software such as the Nanit baby sleeping bag that monitors an infant’s... Continue Reading
News roundup: Proteus may be no-teous, DOJ leads on Google-Fitbit, HHS’ mud fight, Leeds leading in health tech, malware miseries, comings and goings
...a substantial number of investors have put in about $487M in funding through a Series H (Crunchbase), including a game-changing investment by Novartis dating back to 2010. Proteus achieved unicorn status about three years ago, but its high-priced pill tracking technology with a pill sensor tracked by a skin-worn monitor reporting into a smartphone has a built-in limited market to expensive medication. Otsuka Pharmaceutical in 2017 partnered with Proteus for an FDA-cleared digital medicine system called Abilify MyCite that basically put an off-patent behavioral drug back into a more expensive tracking methodology. But Proteus remains a great idea on tracking... Continue Reading
Most Recent Comments